All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 149 of 206 pages ‹ First < 147 148 149 150 151 > Last ›
HSL1050
Pear R.
US to Review Research at Hospitals for Veterans Nationwide
The New York Times 2003 Apr 13
http://www.nytimes.com/2003/04/13/national/13VETS.html
HSL1049
Gottlieb S.
CDC reports first case of vancomycin resistant Staphylococcus aureus
BMJ 2003 Apr 12
http://www.bmj.com/cgi/content/extract/326/7393/783/a
HSL287
Anand G.
Drug Debate: New Antipsychotics Pose a Quandary For FDA, Doctors--- Eli Lilly's Big Seller, Zyprexa, Can Help Schizophrenics; Is It Linked to Diabetes? --- Warnings Abroad, Not in U.S.
Wall Street Journal 2003 Apr 11
HSL1045
Pierson R.
Stroke risk cited in widely used drug
Reuters 2003 Apr 11
http://web.archive.org/web/20030422094006/http://www.boston.com/dailyglobe2/101/nation/Stroke_risk_cited_in_widely_used_drugP.shtml
HSL1047
McGregor G.
MPs to probe drug rule that limits competition
Ottawa Citizen / Canada.Com 2003 Apr 11
HSL1048
Skidmore S.
Medical Partners gives reps access to doctors: For a fee, company manages sales visits
The Florida Times-Union 2003 Apr 11
HSL18163
Luis Jódar F, LaForce M, Ceccarini C, Aguado T, Granoff DM
Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries
Lancet 2003 Apr 10;361:(9370):
http://image.thelancet.com/extras/02art7254web.pdf
HSL1042
Calmes J.
PhRMA Fights Petition to Force State to Act
THE WALL STREET JOURNAL 2003 Apr 9
HSL1043
Gellene D.
Drug-Firm Rivalry Spills Into Congress
Los Angeles Times 2003 Apr 9
http://articles.latimes.com/2003/apr/09/business/fi-amgen9
HSL1044
NZMA calls for ban on DTCA
2003 Apr 9
HSL1040
Fidelman C.
Drug company pitches in Private-Public partnership. Will spend $3 million in government-run diabetes-prevention program
The Gazette 2003 Apr 8
HSL1041
Marshall E.
Despite Negative Impact of WHI and HERS II Studies, the Hormone Replacement Therapy Market will Experience Robust Growth
Decision Resources, Inc. 2003 Apr 8
HSL1039
Angier N.
'Enough': The Dangers of Genetic Technologies
2003 Apr 6
HSL1038
Cohen P.
Visions and Revisions of Child-Raising Experts
The New York Times 2003 Apr 5
http://www.nytimes.com/2003/04/05/books/visions-and-revisions-of-child-raising-experts.html?pagewanted=all
HSL1037
White V.
Lawmakers Accuse FDA of Siding with Industry on Reimportation From Canada
2003 Apr 4
HSL1036
Attitudes to Government Regulation Vary Greatly for Different Industries
2003 Apr 2
HSL1093
FDA inquiry needed
2003 Apr 2
HSL1035
McGregor G.
Victory for Big Drug Makers MPs shelve review of policy that helps keep generic rivals off the market
Ottawa Citizen 2003 Apr 1
HSL5848
Toop L, Richards D, Dowell T.
The leadership role of general practice in public health: advocating a ban of direct-to-consumer advertising of prescription drugs in New Zealand.'Possums in the headlights?'.
Br J Gen Pract. 2003 Apr 1;53:(489):342-5
HSL18183
Gafni A, Birch S.
Inclusion of drugs in provincial drug benefit programs: Should
CMAJ 2003 Apr 1;168:(7):849-51
http://www.cmaj.ca/cgi/content/full/168/7/849
HSL18184
Square D.
Does that free sleeve of golf balls demean the profession?
CMAJ 2003 Apr 1;168:(7):884
http://www.cmaj.ca/cgi/content/full/168/7/884
HSL1210
Gershell LJ, Atkins JH.
A brief history of novel drug discovery technologies.
Nat Rev Drug Discov 2003 Apr;2:(4):321-7
http://www.nature.com/cgi-taf/DynaPage.taf?file=/nrd/journal/v2/n4/abs/nrd1064_fs.html&dynoptions=doi1114934034
HSL1221
Drack G, Kuhn HP, Haller U; Committee for Quality Preservation of the Swiss Society of Gynaecology and Obstetrics.
[Is continuing medical education under suspicion of corruption? Contribution to the discussion by the Committee for Quality Preservation of the Swiss Society of Gynaecology and Obstetrics]
Gynakol Geburtshilfliche Rundsch 2003 Apr;43:(2):111-7
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=GGR43111
HSL1222
Donnan GA, Davis SM, Kaste M; International Trial Subcommittee of the International Stroke Liaison Committee, American Stroke Association.
Recommendations for the relationship between sponsors and investigators in the design and conduct of clinical stroke trials.
Stroke 2003 Apr;34:(4):1041-5
http://stroke.ahajournals.org/cgi/content/full/34/4/1041
HSL1227
Cooper RJ, Schriger DL, Wallace RC, Mikulich VJ, Wilkes MS.
The quantity and quality of scientific graphs in pharmaceutical advertisements.
J Gen Intern Med 2003 Apr;18:(4):294-7
http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0884-8734&date=2003&volume=18&issue=4&spage=294
HSL1253
A review of new drugs and indications in 2002: financial speculation or better patent care?
Prescrire Int 2003 Apr;12:(64):74-7
HSL1515
Prosser H, Walley T.
Understanding why GPs see pharmaceutical representatives: a qualitative interview study.
Br J Gen Pract 2003 Apr;53:(489):305-11
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1314573/?tool=pubmed
HSL10283
Gaba MM.
Federal regulation in the absence of prescription drug legislation: the Bush administration's proposal to speed generics to market.
Tissue Eng 2003 Apr;9:(2):385-7
http://www.liebertonline.com/doi/abs/10.1089%2F107632703764664855
HSL10429
Zolpidem: now classified as a psychotropic at risk of abuse.
Prescrire Int 2003 Apr;12:(64):60
HSL10481
McManus P, Mant A, Mitchell P, Britt H, Dudley J.
Use of antidepressants by general practitioners and psychiatrists in Australia.
Aust N Z J Psychiatry 2003 Apr;37:(2):184-9
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1440-1614.2003.01132.x
HSL10482
Erlich H, Bonnet J, Frueh FW, Bertrand P, Schmitz G, Salvatore G, Little S, Lambert C, Baranova E, Siest G.
Pharmacogenetics: from bench to bedside.
Clin Chem Lab Med 2003 Apr;41:(4):610-4
HSL10485
Wyllie MG.
The phosphodiesterase inhibitor 'war'.
BJU Int 2003 Apr;91:(6):573-4
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1464-410X.2003.04115.x
HSL10501
Carrasquillo O, Goodman RL.
Pharma's bad karma: Resistance is not futile.
J Gen Intern Med 2003 Apr;18:(4):315-6
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1525-1497.2003.30290.x
HSL10502
Shi CW, Asch SM, Fielder E, Gelberg L, Brook RH, Leake B, Shapiro MF, Dowling P, Nichol M.
Usage patterns of over-the-counter phenazopyridine (pyridium).
J Gen Intern Med 2003 Apr;18:(4):281-7
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1525-1497.2003.20709.x
HSL10516
Blazquez A, Arias J, Mateos-Campos R.
Trends in the use of antituberculosis drugs in Spain 1993-1998.
Pharmacoepidemiol Drug Saf 2003 Apr-May;12:(3):227-36
HSL10529
Holdsworth MT.
Pediatric drug research--the road less traveled.
Ann Pharmacother 2003 Apr;37:(4):586-91
http://www.theannals.com/cgi/content/full/37/4/586
HSL10535
Shader RI, Greenblatt DJ.
The safety of over-the-counter drugs: some reflections and unanswered questions.
J Clin Psychopharmacol 2003 Apr;23:(2):111-2
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0271-0749&volume=23&issue=2&spage=111
HSL19518
Final Compliance Program Guidance for Pharmaceutical Manufacturers
U.S. HHS Office of the Inspector General. 2003 Apr
oig.hhs.gov/.../complianceguidance/042803pharmacymfgnonfr.pdf
HSL1027
Carr G.
Climbing the helical staircase
The Economist 2003 Mar 27
http://www.economist.com/surveys/displayStory.cfm?story_id=1647556
HSL1026
FDA Chief Seeks More Balance in Drug Ads
The LA Times 2003 Mar 25
http://articles.latimes.com/2003/mar/25/business/fi-rup25.6
HSL1025
Drug argument embroils psychiatrists, pharm cos: Critics question whether medication trumps other treatments
CNN 2003 Mar 24
http://www.cnn.com/2003/HEALTH/conditions/03/24/health.psychiatry.reut/index.html
HSL19923
Elgin B, Mullaney TJ
Search Engines are picking steam
Business Week Online 2003 Mar 24
http://www.rankforsales.com/news/001-seo-mar-21-03.html
HSL1024
Stone A.
LScan helps drug cos. stem their paper trail
Philadelphia Business Journal 2003 Mar 21
http://philadelphia.bizjournals.com/philadelphia/stories/2003/03/24/focus2.html?page=2
HSL10426
Veryard C.
Russian Pharma-Marcus Evans conference.
IDrugs 2003 Mar 20-21;6:451-453
http://www.biomedcentral.com/1369-7056/6/451
HSL1415
Jureidini JN, Tonkin AL.
Clinical practice guidelines for depression in young people.
Med J Aust 2003 Mar 17;178:(6):300
http://www.mja.com.au/public/issues/178_06_170303/letters_170303-5.html
HSL18188
Nelson MR.
The verdict from ALLHAT.
Med J Aust 2003 Mar 17;178:(6):304
http://www.mja.com.au/public/issues/178_06_170303/letters_170303-12.html
HSL1225
Derauf , Dd .
Surely you jest?
BMJ 2003 Mar 15;325:(7377):1375
http://bmj.com/cgi/eletters/325/7377/1375
HSL1023
Freudenheim M.
Documents Detail Big Payments by Drug Makers to Sway Sales
The New York Times 2003 Mar 13
http://www.nytimes.com/2003/03/13/business/documents-detail-big-payments-by-drug-makers-to-sway-sales.html
HSL1021
Kowalczyk L.
Whistle-blower tells of 'illegal' tactics : Says drug firm taught deception
The Boston Globe 2003 Mar 12
HSL1022
Petersen M.
Pfizer Nears Drug Settlement
The New York Times 2003 Mar 12
HSL5369
Petersen M.
Doctor explains why he blew the whistle
New York Times 2003 Mar 12C1
HSL1020
Friedman R.
Do Spelling and Penmanship Count? In Medicine, You Bet
The New York Times 2003 Mar 11
http://www.nytimes.com/2003/03/11/health/cases-do-spelling-and-penmanship-count-in-medicine-you-bet.html
HSL1177
Vilardell M.
Drug advertising in medical journals.
Lancet 2003 Mar 8;361:(9360):879
HSL1182
Simmonds H.
Drug advertising in medical journals.
Lancet 2003 Mar 8;361:(9360):878-9
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T1B-48400HM-18&_coverDate=03%2F08%2F2003&_alid=272343695&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=4886&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=5cb97991633cfb6b2994c35dbcd55662
HSL1184
Peiró S, Librero J, Villanueva P, Inmaculad P.
Drug advertising in medical journals: Authors' reply
Lancet 2003 Mar 8;361:(9360):878
HSL1188
Mansfield PR, Lexchin J, Vitry A, Doecke CJ, Svensson S.
Drug advertising in medical journals.
Lancet 2003 Mar 8;361:(9360):879
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T1B-48400HM-1B&_coverDate=03%2F08%2F2003&_alid=272642718&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=4886&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=fa10917712438764944ab5277ec07357
HSL1192
Lopez-Gil A.
Drug advertising in medical journals.
Lancet 2003 Mar 8;361:(9360):877-8
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T1B-48400HM-16&_coverDate=03%2F08%2F2003&_alid=272643901&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=4886&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=924e6e6fa3ffdd2e4795b44fcfc7b69d
HSL1217
Ferner RE.
Drug advertising in medical journals.
Lancet 2003 Mar 8;361:(9360):879
http://www.thelancet.com/journal/vol361/iss9360/full/llan.361.9360.correspondence.24819.1
HSL18097
Kwon S
Pharmaceutical reform and physician strikes in Korea: separation of drug prescribing and dispensing
Social Science & Medicine 2003 Mar 6;57:(3):
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-482YTNH-1&_user=10&_handle=W-WA-A-A-AZ-MsSAYWW-UUW-AUZYBCZVCZ-YZYVUZWU-AZ-U&_fmt=summary&_coverDate=08/31/2003&_rdoc=12&_orig=browse&_srch=#toc#5925#2003#999429996#1!&_cdi=5925&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=3896dcc24ee9b2c48f62fa89bb1266ea
HSL1018
Koerner B.
Dr. No Free Lunch: Hellraiser: Bob Goodman
Mother Jones 2003 Mar 3
http://motherjones.com/politics/2003/03/dr-no-free-lunch
HSL1019
Nitkin D.
Md. bill targets gifts to doctors
The Baltimore Sun 2003 Mar 3
http://www.baltimoresun.com/entertainment/bal-md.doctors03mar03,0,3126408.story
HSL18187
Newby DA, Fryer JL, Henry DA.
Effect of computerised prescribing on use of antibiotics.
Med J Aust 2003 Mar 3;178:(5):210-3
http://www.mja.com.au/public/issues/178_05_030303/new10320_fm.html
HSL18189
Liaw ST, Pearce CM, Chondros P, McGrath BP, Piggford L, Jones K.
Doctors' perceptions and attitudes to prescribing within the Authority Prescribing System.
Med J Aust 2003 Mar 3;178:(5):203-6
http://www.mja.com.au/public/issues/178_05_030303/lia10050_fm.html
HSL1028
Mundy A.
Hot Flash, Cold Cash
Washington Monthly 2003 Feb/Mar
http://www.washingtonmonthly.com/features/2001/0301.mundy.html
HSL18191
Burton B
Ban direct to consumer advertising, report recommends
BMJ 2003 Mar 1;326:(7387):467
http://www.bmj.com/cgi/content/extract/326/7387/467/a
HSL1126
Office of Inspector General, Dept of Health and Human Services.
FDA’s Review Process for New Drug Applications: A Management Review
2003 Mar
http://oig.hhs.gov/oei/reports/oei-01-01-00590.pdf
HSL1255
Yasmin advert withdrawn--why and how
Drug Ther Bull 2003 Mar;14:(3):17-8
HSL1822
Koch DD.
Industry support for physician education.
J Cataract Refract Surg 2003 Mar;29:(3):419
http://linkinghub.elsevier.com/retrieve/pii/S0886335003001056
HSL1901
Schatz R, Belloto RJ Jr, White DB, Bachmann K.
Provision of drug information to patients by pharmacists: the impact of the Omnibus Budget Reconciliation Act of 1990 a decade later.
Am J Ther 2003 Mar-Apr;10:(2):93-103
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=1075-2765&volume=10&issue=2&spage=93
HSL1908
Olson BM, Armstrong EP, Grizzle AJ, Nichter MA.
Industry's perception of presenting pharmacoeconomic models to managed care organizations.
J Manag Care Pharm 2003 Mar-Apr;9:(2):159-67
HSL7644
Dewar JC, Hall IP.
Personalised prescribing for asthma--is pharmacogenetics the answer?
J Pharm Pharmacol 2003 Mar;55:(3):279-89
http://www.ingentaconnect.com/content/rpsgb/jpp/2003/00000055/00000003/art00001?token=004810963048296a7c2849266d656c595c5f3b3b47675648663b707b7476457a31e78616
HSL9949
Renfrey S, Downton C, Featherstone J.
The painful reality.
Nat Rev Drug Discov 2003 Mar;2:(3):175-6
HSL10509
Fleming J.
Health information on the Internet.
J R Soc Health 2003 Mar;123:(1):10-1
HSL10527
Ufer M, Rane A, Karlsson A, Kimland E, Bergman U.
Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in Stockholm.
Eur J Clin Pharmacol 2003 Mar;58:(11):779-83
http://www.springerlink.com/content/yj09pk6cxp4gcw5d/
HSL10618
Frank RG.
New estimates of drug development costs.
J Health Econ 2003 Mar;22:(2):325-30
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6V8K-47W5NVS-1&_user=10&_coverDate=03%2F31%2F2003&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=d1353c9e6f6151034587ab40f88c4376
HSL10628
Wysowski DK, Swann J.
Use of medications for erectile dysfunction in the United States, 1996 through 2001.
J Urol 2003 Mar;169:(3):1040-2
http://linkinghub.elsevier.com/retrieve/pii/S0022-5347(05)63883-9
HSL13308
Sleath B, Shih YC.
Sociological influences on antidepressant prescribing.
Soc Sci Med 2003 Mar;56:(6):1335-44
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-45XR7RB-6&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=893985323b5cdcc788511ca4d3bde959
HSL1016
Saillant C.
Sending a Message to Drug Maker: Seven Marina del Rey doctors join a boycott against Glaxo over the firm's Canada policy.
LA Times 2003 Feb 27
http://articles.latimes.com/2003/feb/27/local/me-doctors27
HSL19925
Drazen JM
Inappropriate Advertising of Dietary Supplements
NEJM 2003 Feb 27;348:(9):777
http://www.nejm.org/doi/full/10.1056/NEJMp030021
HSL1015
Survey shows benefits of prescription drug advertising, few adverse effects
Health Affairs 2003 Feb 26
http://www.scienceblog.com/community/older/2003/E/20033003.html
HSL1014
Keep Drug-Sponsored 'Patient Channel' Out of Hospitals, Doctors Say
Commerical Alert 2003 Feb 25
http://www.commercialalert.org/issues/health/drug-marketing/keep-drug-sponsored-patient-channel-out-of-hospitals-doctors-say
HSL7981
Petersen M, Berenson A.
Papers Indicate That Bayer Knew of Dangers of Its Cholesterol Drug
New York Times 2003 Feb 23Health
http://query.nytimes.com/gst/fullpage.html?sec=health&res=9B00EEDC103DF931A15751C0A9659C8B63
HSL18192
Garattini S, Bertele' V, Li Bassi L.
Light and shade in proposed revision of EU drug-regulatory legislation.
Lancet 2003 Feb 22;361:(9358):635-6
http://linkinghub.elsevier.com/retrieve/pii/S0140673603126153
HSL18229
Taylor D.
Fewer new drugs from the pharmaceutical industry.
BMJ 2003 Feb 22;326:(7386):408-9
http://www.bmj.com/cgi/content/full/326/7386/408?view=long&pmid=12595352
HSL20181
Debating drug advertising
Massey University News 2003 Feb 22
http://www.massey.ac.nz/~wwpubafs/2003/masseynews/feb/feb24/drug_ads.html
HSL1013
Koechlin F.
Gene tests - the El Dorado of genetic engineering?
2003 Feb 20
HSL18194
Studdert DM, Mello MM, Brennan TA
Medical Monitoring for Pharmaceutical Injuries - Tort Law for the Public's Health?
JAMA 2003 Feb 19;289:(7):889
http://jama.ama-assn.org/cgi/content/abstract/289/7/889
HSL18195
Studdert DM, Mello MM, Brennan TA
Survey Suggesting That Prescription Drug Ads Help Public Is Met With Skepticism
JAMA 2003 Feb 19;289:(7):827
http://jama.ama-assn.org/cgi/content/extract/289/7/827
HSL18261
Mitka M
Survey Suggesting That Prescription Drug Ads Help Public Is Met With Skepticism
JAMA 2003 Feb 19;289:(7):
http://www.ncbi.nlm.nih.gov/pubmed/12588246
HSL18220
Sullivan P
MD's affidavit decries company's use of prescription data mining
CMAJ 2003 Feb 18;168:(4):469
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC143563/
HSL20182
Prescription advertising has benefits say health professionals
Massey University News 2003 Feb 18
http://www.massey.ac.nz/~wwpubafs/2003/press_releases/18_02_03b.html
HSL18223
Moynihan R.
US seniors group attacks pharmaceutical industry 'fronts'.
BMJ 2003 Feb 15;326:(7385):351
http://www.bmj.com/cgi/content/full/326/7385/351?view=long&pmid=12586647
HSL20183
Massey Researchers Question Otago DTCA Survey
Massey University News 2003 Feb 14
http://www.massey.ac.nz/~wwpubafs/2003/press_releases/14_02_03.html
HSL1012
Lawsuit Charges Drug Makers Stifled Competition
2003 Feb 13
HSL18224
Dobson R
Pharmaceutical industry is main influence in GP prescribing
BMJ 2003 Feb 8;326:(7384):301
http://www.bmj.com/cgi/content/extract/326/7384/301
HSL1011
Barnett A.
Patients used as drug 'guinea pigs': Firms pay out millions to doctors to test medicines
The Observer 2003 Feb 7
http://www.guardian.co.uk/politics/2003/feb/09/health.nhs
HSL1010
Herper M.
Prescription Drug Ads Are No Blockbusters
Forbes 2003 Feb 5
http://www.forbes.com/2003/05/02/cx_mh_0502drugsads.html
HSL18221
We need Romanow's National Drug Agency
CMAJ 2003 Feb 4;168:(3):249
http://www.cmaj.ca/cgi/content/full/168/3/249
HSL18222
Sibbald B
Dispute over use of MDs' prescribing information heading to court
CMAJ 2003 Feb 4;168:(8):325
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC140480/
HSL1017
Ballenden N.
The Hard Sell
Consuming Interest (Australia) 2003 Feb
Page 149 of 206 pages ‹ First < 147 148 149 150 151 > Last ›
